Skip to main content

ovarian cancer Archives

Chic Awearness event supports VUMC ovarian cancer research

Sep. 13, 2017—The annual Chic Awearness fundraising event that supports ovarian cancer research at major medical centers, including Vanderbilt University Medical Center (VUMC), will be held Monday, Sept. 25, 6:30 – 8:30 p.m., at Prima Restaurant, 700 12th Ave. South.

Read more


Blood type link to cancer survival

May. 17, 2017—Blood type A was associated with longer ovarian cancer survival in a recent Vanderbilt-led study.

Read more


VICC ovarian cancer funding opportunity

Mar. 14, 2017—The Vanderbilt-Ingram Cancer Center (VICC) announces a funding opportunity to catalyze innovative, collaborative ovarian cancer-related projects.

Read more


Know the facts about ovarian cancer

Sep. 16, 2016—Listening to the body and being aware of individual risks are especially important when it comes to ovarian cancer. Vanderbilt–Ingram Cancer Center provides the facts.

Read more


Fashion show to benefit VICC ovarian cancer research

Sep. 15, 2016—Fall fashions for women will be on display during the 4th Annual Chic Awearness Fashion Show promoting ovarian cancer awareness and research. The event, to be held Monday, Sept. 26, 6:30 to 8:30 p.m., will benefit the T.J. Martell Foundation, which supports ovarian cancer research at Vanderbilt-Ingram Cancer Center (VICC).

Read more


New lead for ovarian cancer treatment

Dec. 10, 2015—Combining inhibitors of the BMP signaling pathway with standard chemotherapy drugs may overcome drug resistance in ovarian cancer.

Read more


Nominations sought for 2016 Mary Kay Foundation Cancer Research Grant

Nov. 13, 2015—Vanderbilt University may nominate one candidate for the Mary Kay Foundation Translational Cancer Research Grant program for 2016.

Read more


Drug combos enhance ovarian cancer cell death

Aug. 11, 2015—Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities.

Read more


VICC receives $100,000 ovarian cancer research grant

Jan. 21, 2014—The Kay Yow Cancer Fund, in partnership with the Women’s Basketball Coaches Association and The V Foundation for Cancer Research, has awarded a $100,000 ovarian cancer research grant to the Vanderbilt-Ingram Cancer Center.

Read more


Universitywide Limited Submission Opportunity: Translational cancer research grant from the Mary Kay Foundation

Nov. 13, 2013—Vanderbilt University may nominate one candidate for the Mary Kay Foundation Translational Cancer Research Grant program for 2014. These awards provide $100,000 over two years for investigators involved in translational research in ovarian, uterine, breast or cervical cancer. The Mary Kay Foundation seeks to fund innovative research that will provide a scientific link between laboratory research...

Read more


Molecular circuits in ovarian cancer

Nov. 13, 2013—Vanderbilt researchers have used bioinformatics analysis of gene expression data to describe molecular “circuits” that drive ovarian cancer.

Read more


Overcoming resistance in ovarian cancer

Aug. 22, 2013—The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.

Read more


Page 1 of 212